3416400779

BIBLIOGRAPHIE

Matsui, K., Fine, A., Zhu, B., Marshak-Rothstein, A. and Ju, S.T. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T celi hybridoma. J Immunol 1998; 161: 3469-3473.

Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K. and Elledge, S.J. Ataxia teiangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci U SA 2000; 97: 10389-10394.

Mayo, L.D., Turchi, J.J. and Berberich, S.J. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. Cancer Res 1997; 57: 5013-5016.

McBride, A.A., Byrne, J.C. and Howley, P.M. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc Natl Acad Sci USA 1989; 86: 510-514.

McBride, A.A., Romańczuk, H. and Howley, P.M. The papillomavirus E2 regulatory proteins. J Biol Chem 1991; 266: 18411-18414.

McGlennen, R.C. Humań papillomavirus oncogenesis. Clin Lab M?ć/2000; 20: 383-406.

McIIwrath, A.J., Vasey, P.A., Ross, G.M. and Brown, R. Celi cycle arrests and radiosensitivity of human tumor celi lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 1994; 54: 3718-3722.

Mclntyre, M.C., Frattini, M.G., Grossman, S.R. and Laimins, L.A. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J Virol 1993; 67: 3142-3150.

Mclntyre, M.C., Ruesch, M.N. and Laimins, L.A. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and pl07. Virology 1996; 215: 73-82.

McKay, L.I. and Cidlowski, J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 1999; 20: 435-459.

McKenna, W.G., Iliakis, G., Weiss, M.C., Bernhard, EJ. and Muschcl, R.J. Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat Res 1991; 125: 283-287.

Meek, D.W. Multisite phosphorylation and the integration of stress signals at p53. Celi Signal 1998; 10: 159-166.

Mercer, W.E. Checking on the celi cycle. J Celi Blochem Suppl 1998; 30-31: 50-54.

Merika, M., Williams, A.J., Chen, G., Collins, T. and Thanos, D. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Celi 1998; 1: 277-287.

Meyer, A.N., Xu, Y.F., Webster, M.K., Smith, A.E. and Donoghue, D.J. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papiIlomavirus E5 oncoprotein. Proc Natl Acad Sci USA 1994; 91: 4634-4638.

Meyer, S., Kohler, N.G. and Joly, A. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation. FEBS Lett 1997; 413: 354-358.

Mirjolet, J.F. Role de la Thyniidylate Synthase et de P53 dans la resistance cellulaire au 5-Fluorouracile. These de l'Universite Henri Poicare - Nancy 12000.

Mirjolet, J.F., Barberi Heyob, M., Didelot, C., Pcyrat, J.P., Abecassis, J., Milion, R. and Merlin, J.L. Bcl-2/Bax protein ratio predicts 5-fIuorouracil sensitivity independently of p53 status. Br J Cancer 2000; 83: 1380-1386.

Miyashita, T., Harigai, M., Hanada, M. and Reed, J.C. Identification of a p53-dependent negative response element in the bcI-2 gene. Cancer Res 1994a; 54: 3131-3135.

178